Moderna, Inc.
MRNAFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
3,199
Cost of Revenue
1,464
Gross Profit
1,735
Gross Margin
54.2%
Operating Income
-3,945
Operating Margin
-123.3%
Net Income
-3,561
Net Margin
-111.3%
EPS (Basic)
$-9.27
EPS (Diluted)
$-9.27
EBITDA
-3,394
EBITDA Margin
-106.1%
2023
12/31/2023
Revenue
6,848
Cost of Revenue
4,693
Gross Profit
2,155
Gross Margin
31.5%
Operating Income
-4,239
Operating Margin
-61.9%
Net Income
-4,714
Net Margin
-68.8%
EPS (Basic)
$-12.34
EPS (Diluted)
$-12.34
EBITDA
-3,283
EBITDA Margin
-47.9%
2022
12/31/2022
Revenue
18,875
Cost of Revenue
5,416
Gross Profit
13,459
Gross Margin
71.3%
Operating Income
9,420
Operating Margin
49.9%
Net Income
8,362
Net Margin
44.3%
EPS (Basic)
$21.26
EPS (Diluted)
$20.10
EBITDA
9,768
EBITDA Margin
51.8%
2021
12/31/2021
Revenue
17,736
Cost of Revenue
2,617
Gross Profit
15,119
Gross Margin
85.2%
Operating Income
13,296
Operating Margin
75.0%
Net Income
12,202
Net Margin
68.8%
EPS (Basic)
$30.31
EPS (Diluted)
$28.29
EBITDA
13,528
EBITDA Margin
76.3%
2020
12/31/2020
Revenue
803
Cost of Revenue
39
Gross Profit
764
Gross Margin
95.1%
Operating Income
-763
Operating Margin
-95.0%
Net Income
-747
Net Margin
-93.0%
EPS (Basic)
$-1.96
EPS (Diluted)
$-1.96
EBITDA
-703
EBITDA Margin
-87.6%